News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,429 Results
Type
Article (34546)
Company Profile (163)
Press Release (522715)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (155283)
Career Advice (747)
Deals (25332)
Drug Delivery (82)
Drug Development (59897)
Employer Resources (80)
FDA (14382)
Job Trends (11954)
News (260355)
Policy (24285)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2318)
Accelerated approval (19)
Adcomms (10)
Allergies (128)
Alliances (43660)
ALS (113)
Alzheimer's disease (1251)
Antibody-drug conjugate (ADC) (246)
Approvals (14728)
Artificial intelligence (492)
Autoimmune disease (118)
Automation (33)
Bankruptcy (211)
Best Places to Work (9744)
BIOSECURE Act (10)
Biosimilars (92)
Biotechnology (119)
Bladder cancer (132)
Brain cancer (48)
Breast cancer (495)
Cancer (3837)
Cardiovascular disease (305)
Career advice (678)
Career pathing (20)
CAR-T (244)
CDC (29)
Celiac Disease (2)
Cell therapy (628)
Cervical cancer (35)
Clinical research (51977)
Collaboration (1506)
Compensation (434)
Complete response letters (23)
COVID-19 (2104)
CRISPR (89)
C-suite (695)
Cystic fibrosis (99)
Data (5087)
Decentralized trials (2)
Denatured (37)
Depression (102)
Diabetes (388)
Diagnostics (6115)
Digital health (41)
Diversity (11)
Diversity, equity & inclusion (17)
Drug discovery (205)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (169)
Earnings (57550)
Editorial (34)
Employer branding (12)
Employer resources (73)
Events (80429)
Executive appointments (805)
FDA (17093)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (184)
Generative AI (43)
Gene therapy (463)
GLP-1 (701)
Government (3593)
Grass and pollen (6)
Guidances (322)
Healthcare (15611)
HIV (49)
Huntington's disease (25)
IgA nephropathy (60)
Immunology and inflammation (120)
Immuno-oncology (33)
Indications (83)
Infectious disease (2312)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (97)
Intellectual property (192)
Interviews (78)
IPO (11005)
IRA (29)
Job creations (2571)
Job search strategy (598)
JPM (30)
Kidney cancer (12)
Labor market (49)
Layoffs (283)
Leadership (12)
Legal (4977)
Liver cancer (77)
Longevity (11)
Lung cancer (548)
Lymphoma (302)
Machine learning (38)
Management (30)
Manufacturing (611)
MASH (121)
Medical device (14459)
Medtech (14511)
Mergers & acquisitions (15111)
Metabolic disorders (909)
Multiple sclerosis (119)
NASH (12)
Neurodegenerative disease (224)
Neuropsychiatric disorders (52)
Neuroscience (2145)
NextGen: Class of 2026 (5405)
Non-profit (3425)
Now hiring (39)
Obesity (373)
Opinion (163)
Ovarian cancer (145)
Pain (173)
Pancreatic cancer (170)
Parkinson's disease (208)
Partnered (25)
Patents (392)
Patient recruitment (410)
Peanut (53)
People (48867)
Pharmaceutical (29)
Pharmacy benefit managers (17)
Phase 1 (16104)
Phase 2 (22698)
Phase 3 (17500)
Pipeline (4067)
Policy (159)
Postmarket research (1809)
Preclinical (6235)
Press Release (67)
Prostate cancer (199)
Psychedelics (27)
Radiopharmaceuticals (240)
Rare diseases (568)
Real estate (4666)
Recruiting (33)
Regulatory (19211)
Reports (22)
Research institute (2139)
Resumes & cover letters (102)
Rett syndrome (26)
RNA editing (11)
RSV (58)
Schizophrenia (123)
Series A (194)
Series B (143)
Service/supplier (7)
Sickle cell disease (61)
Special edition (7)
Spinal muscular atrophy (120)
Sponsored (30)
Startups (3235)
State (2)
Stomach cancer (12)
Supply chain (78)
Tariffs (31)
The Weekly (37)
Vaccines (772)
Venture capital (53)
Weight loss (238)
Women's health (70)
Worklife (6)
Date
Today (18)
Last 7 days (416)
Last 30 days (1738)
Last 365 days (22694)
2026 (2080)
2025 (23112)
2024 (27750)
2023 (31918)
2022 (42314)
2021 (45758)
2020 (44559)
2019 (39090)
2018 (29739)
2017 (26810)
2016 (25742)
2015 (30025)
2014 (22809)
2013 (19194)
2012 (20786)
2011 (21282)
2010 (19643)
Location
Africa (532)
Alabama (76)
Alaska (6)
Arizona (241)
Arkansas (13)
Asia (35089)
Australia (5912)
California (8095)
Canada (2636)
China (979)
Colorado (376)
Connecticut (399)
Delaware (287)
Europe (74313)
Florida (1338)
Georgia (301)
Hawaii (3)
Idaho (50)
Illinois (714)
India (45)
Indiana (438)
Iowa (17)
Japan (404)
Kansas (121)
Kentucky (28)
Louisiana (22)
Maine (36)
Maryland (1137)
Massachusetts (5537)
Michigan (321)
Minnesota (518)
Mississippi (5)
Missouri (119)
Montana (30)
Nebraska (26)
Nevada (84)
New Hampshire (83)
New Jersey (2431)
New Mexico (22)
New York (2187)
North Carolina (1125)
North Dakota (10)
Northern California (3771)
Ohio (286)
Oklahoma (18)
Oregon (37)
Pennsylvania (1687)
Puerto Rico (22)
Rhode Island (43)
South America (779)
South Carolina (66)
South Dakota (1)
Southern California (3243)
Tennessee (144)
Texas (1338)
United States (30094)
Utah (288)
Vermont (1)
Virginia (179)
Washington D.C. (58)
Washington State (710)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
557,429 Results for "magnolia medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Magnolia Medical Appoints Jason Richey as President & Chief Executive Officer
July 30, 2025
·
2 min read
Press Releases
Stratus Medical raises $10 million Series B to complete development of new technology and fund clinical trial
February 4, 2026
·
3 min read
BioForest
Magnolia Medical Technologies Marks World AMR Awareness Week by Recognizing the Need to Reduce Antibiotic Usage through Accurate Blood Culture Results
In observance of World AMR Awareness Week (WAAW), Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) and the ISDD market to prevent false-positive sepsis tests, is driving efforts to highlight the role of diagnostic stewardship in combating the risk of AMR.
November 20, 2023
·
6 min read
BioForest
In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis
Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month.
September 7, 2023
·
7 min read
Press Releases
Belmont Medical Technologies Appoints Brian Larkin as Chief Executive Officer
February 4, 2026
·
4 min read
Biotech Beach
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.
August 15, 2023
·
1 min read
Biotech Beach
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, provided an update on the ongoing patent infringement case brought against Kurin by Magnolia Medical.
August 10, 2023
·
2 min read
Policy
Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.
A jury for the U.S. District Court of Delaware delivered two unanimous verdicts this week in favor of Magnolia Medical Technologies, Inc. (“Magnolia Medical”) in a lawsuit against Kurin, Inc., (“Kurin”) regarding the unlawful use of its innovative Initial Specimen Diversion Device® (ISDD®) technology.
July 29, 2022
·
3 min read
Policy
Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products
Magnolia Medical Technologies, Inc. (“Magnolia Medical”) today announced it filed a motion for permanent injunction in the U.S. District Court for the District of Delaware on September 9, 2022, that would prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock products.
September 13, 2022
·
4 min read
Press Releases
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
January 8, 2026
·
4 min read
1 of 55,743
Next
